Nano X Imaging Ltd (NNOX) — Quality & forensics
As of 2026-10-19 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 31
- Quality 1
- Growth 60
- Balance sheet 42
- Cash quality 41
- Capital allocation 8
- Momentum 0
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the distress zone (below 1.81). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the NNOX chart & overview
FAQ · from the current data · as of 2026-10-19
Quick answers
What is Nano X Imaging Ltd's Closelooknet quality reading?
The composite reads 28/100 across 7 modules, as of 2026-10-19: valuation 31, quality 1, growth 60, balance sheet 42, cash quality 41, capital allocation 8, momentum 0. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Nano X Imaging Ltd's Altman Z-Score?
-3.71, which sits in the distress zone (below 1.81) as of 2026-10-19. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Nano X Imaging Ltd's Piotroski F-Score?
2 of 8, as of 2026-10-19. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Nano X Imaging Ltd's Beneish M-Score indicate?
-3.36 — below the −1.78 manipulation-risk threshold, as of 2026-10-19. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Medical Devices, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- DXCM Dexcomindustry
- SECT-B.ST Sectraindustry
- GMED Globus Medicalindustry
- SNN Smith & Nephew SNATS Incindustry
- SOON.SW Sonovaindustry
- SYK Strykerindustry
- CEVI.ST CellaVisionindustry
- HALO Halozyme Therapeutics Incsector
- ONC BeiGene, Ltd.sector
- MEDP Medpace Holdings Incsector
- RIGL Rigel Pharmaceuticals Incsector
- BTSG BTSG.USsector
- APGE APGE.USsector
- ALKS ALKS.USsector
- ASND ASND.USsector
- BBIO BBIO.USsector
- ARGX ARGX.USsector
- AXSM AXSM.USsector
- ARWR ARWR.USsector
- CGEM CGEM.USsector